blood | 2 Minute Medicine

The 2 Minute Medicine Podcast Episode 15

The 2 Minute Medicine Podcast Episode 25

October 5, 2023

Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

byKathleen Lau

June 12, 2022

0

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

byKathleen Lau

December 31, 2021

0

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

byKathleen Lau

December 18, 2021

0

$#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma$

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

byKathleen Lau

December 2, 2021

0

#VisualAbstract Intensive chemotherapy is associated with better long-term survival in older patients with acute myeloid leukemia

byKathleen Lau

November 27, 2021

0

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

byKathleen Lau

November 19, 2021

0

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

byKathleen Lau

November 12, 2021

0

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

byKathleen Lau

November 11, 2021

0

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

byKathleen Lau

October 28, 2021

0

Tag: blood

The 2 Minute Medicine Podcast Episode 25

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

#VisualAbstract Intensive chemotherapy is associated with better long-term survival in older patients with acute myeloid leukemia

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

#VisualAbstract Transplantation with omidubicel showed faster hematopoietic recovery and fewer early complications compared to standard myeloablative umbilical cord blood graft

Recent Reports